Inappropriate LABA use may explain child asthma deaths

Inappropriate use of ICS–LABA combination therapy may be behind the 20 child asthma deaths in NSW over the last decade, an expert says. Writing in a perspective article in this week’s MJA Professor Peter van Asperen, a paediatric respiratory physician at Westmead Hospital in Sydney said a review of the deaths showed a large number ...